Summary by Moomoo AI
Stuart A Arbuckle, an officer at Vertex Pharmaceuticals Inc, is set to sell 5,034 shares of common stock on 02/26/2024, with an aggregate market value of approximately $2,142,973.80. The shares to be sold were recently acquired on 02/24/2024 as compensation, with half being performance shares and the other half from restricted stock vesting, both sourced from the issuer. Over the past three months, Arbuckle has sold a total of 21,305 shares, generating gross proceeds of $8,778,640.27. The upcoming sale follows a pattern of recent transactions, indicating ongoing trading activity by the officer.